Creative Medical Technology Holdings (CELZ) Assets (2010 - 2026)
Creative Medical Technology Holdings (CELZ) posted quarterly Assets of $6.4 million for Q1 2026, down 22.84% year-over-year from $8.3 million in Q1 2025, and down 17.53% quarter-over-quarter from $7.8 million in Q4 2025.
Creative Medical Technology Holdings (CELZ) Assets (2010 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Assets for 17 consecutive years, with $6.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 22.84% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (down 22.84% YoY), while the FY2025 annual figure was $7.8 million, up 17.1% from the prior year.
- Assets eased to $6.4 million in Q1 2026 per CELZ's latest filing, from $7.8 million in the prior quarter.
- Across five years, Assets topped out at $23.4 million in Q2 2022 and bottomed at $5.9 million in Q3 2025.
- Historically, Assets has averaged $11.4 million across 5 years, with a median of $9.6 million in 2024.
- Annual changes were most pronounced in 2022 — Assets soared 3100.04% — and 2024, when it sank 44.96%.
- Creative Medical Technology Holdings' Assets stood at $19.2 million in 2022, then plunged by 44.15% to $10.7 million in 2023, then plunged by 37.76% to $6.7 million in 2024, then grew by 17.1% to $7.8 million in 2025, then slipped by 17.53% to $6.4 million in 2026.
- Business Quant data shows CELZ's Assets at $6.4 million in Q1 2026, $7.8 million in Q4 2025, and $5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | 9.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.38 Mn |
| Mar 31, 2026 | 6.44 Mn |
| Dec 31, 2025 | 7.81 Mn |
| Sep 30, 2025 | 5.85 Mn |
| Jun 30, 2025 | 7.11 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Dec 31, 2024 | 6.67 Mn |
| Sep 30, 2024 | 6.89 Mn |
| Jun 30, 2024 | 7.99 Mn |
| Mar 31, 2024 | 9.62 Mn |
| Dec 31, 2023 | 10.72 Mn |
| Sep 30, 2023 | 12.51 Mn |
| Jun 30, 2023 | 14.13 Mn |
| Mar 31, 2023 | 15.23 Mn |
| Dec 31, 2022 | 19.19 Mn |
| Sep 30, 2022 | 22.47 Mn |
| Jun 30, 2022 | 23.43 Mn |
| Mar 31, 2022 | 9.73 Mn |
| Dec 31, 2021 | 11.27 Mn |
| Sep 30, 2021 | 3.13 Mn |